Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10 mg Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 44 💬
25 mg Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 44 💬
3Adalimumab, plus prednisone
(D00473)		[2] Adalimumab,
Prednisone		[2] Prednisone (D00473),
Adalimumab 💬		[2] NR3C1,
TNF 💬		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
4Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
(D00473)		[4] Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[4] Methylprednisolone ,
Prednisone (D00473),
Mycophenolate mofetil ,
Mycophenolic acid 💬		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬[1] 49 💬
5Azathioprine/prednisone
(D00473)		[2] Azathioprine,
Prednisone		[2] Azathioprine ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 85 💬
6Capsule di prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
7Chinese Herb Prescription Granule plus prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
8Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
(D00473)		[7] Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		[6] Hydrocortisone ,
Dexamethasone ,
Prednisolone ,
Prednisone (D00473),
Cortisone acetate ,
Cortisone 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
9Corticosteroids (prednisone or prednisolone)
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
10Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
(D00473)		[4] Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		[5] Azathioprine ,
Cyclophosphamide ,
Methylprednisolone ,
Prednisone (D00473),
Cyclophosphamide 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
11Cyclophosphamide-prednisone-azathioprine
(D00473)		[3] Azathioprine,
Cyclophosphamide,
Prednisone		[4] Azathioprine ,
Cyclophosphamide ,
Prednisone (D00473),
Cyclophosphamide 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
12Glucocorticoid (prednisone or prednisolone)
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
13Granulocyte-colony stimulating factor (G-CSF) and prednisone
(D00473)		[2] Filgrastim,
Prednisone		[2] Prednisone (D00473),
Filgrastim 💬		[2] CSF3R,
NR3C1 💬		[6] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 13 💬
14Hormone (prednisone)
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
15Hydroxychloroquine + low-dose prednisone
(D00473)		[2] Hydroxychloroquine,
Prednisone		[2] Prednisone (D00473),
Hydroxychloroquine 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
16Hydroxychloroquine + Prednisone
(D00473)		[2] Hydroxychloroquine,
Prednisone		[2] Prednisone (D00473),
Hydroxychloroquine 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
17IR Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
18Leflunomide 20 mg+prednisone 0.5mg/kg/d
(D00473)		[2] Leflunomide,
Prednisone		[2] Prednisone (D00473),
Leflunomide 💬		[2] DHODH,
NR3C1 💬		[4] Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬[1] 66 💬
19Methylprednisolone (MP) or prednisone (pred)
(D00473)		[2] Methylprednisolone,
Prednisone		[2] Methylprednisolone ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
20Methylprednisone/Prednisone
(D00473)		[2] Methylprednisone,
Prednisone		[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 85 💬
21MR Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
22Mycophenolate mofetil plus lower dose of Prednisone
(D00473)		[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[3] Prednisone (D00473),
Mycophenolate mofetil ,
Mycophenolic acid 💬		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬[1] 66 💬
23Oral Prednisone 5mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
24Over encapsulated prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
25Prednisolone/Prednisone
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
26Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[45] 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
27Prednisone (and methylprednisolone)
(D00473)		[2] Methylprednisolone,
Prednisone		[2] Methylprednisolone ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
28Prednisone + Inhibace/Cozaar
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
29Prednisone - Azathioprine
(D00473)		[2] Azathioprine,
Prednisone		[2] Azathioprine ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 11 💬
30Prednisone 0,5 mg/kg orally on alternate days
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
31Prednisone 1 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
32Prednisone 15 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
33Prednisone 2 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
34Prednisone 3 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
35Prednisone 4 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
36Prednisone 5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 46, 66 💬
37Prednisone 5 mg tablets
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
38Prednisone 7.5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
39Prednisone acetate
(D00473)		[3] Acetate,
Prednisone,
Prednisone acetate		[2] Prednisone (D00473),
Prednisone acetate 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 46, 49, 224 💬
40Prednisone Acetate Tablets
(D00473)		[3] Acetate,
Prednisone,
Prednisone acetate		[2] Prednisone (D00473),
Prednisone acetate 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 224 💬
41Prednisone alone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 11, 66 💬
42Prednisone and Belimumab
(D00473)		[2] Belimumab,
Prednisone		[2] Prednisone (D00473),
Belimumab 💬		[2] NR3C1,
TNFSF13B 💬		[5] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬[1] 300 💬
43Prednisone and cyclophosphamide
(D00473)		[2] Cyclophosphamide,
Prednisone		[3] Cyclophosphamide ,
Prednisone (D00473),
Cyclophosphamide 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
44Prednisone and Mycophenolate mofetil
(D00473)		[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[3] Prednisone (D00473),
Mycophenolate mofetil ,
Mycophenolic acid 💬		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬[1] 300 💬
45Prednisone and ustekinumab treatment
(D00473)		[2] Prednisone,
Ustekinumab		[2] Prednisone (D00473),
Ustekinumab 💬		[4] IL12A,
IL12B,
IL23A,
NR3C1 💬		[29] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 41 💬
46PREDNISONE ARROW 20mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
47PREDNISONE ARROW 5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
48Prednisone Capsule
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
49Prednisone Capsules
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
50Prednisone discontinuation
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
51PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 19 💬
52PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 300 💬
53Prednisone in full dose
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
54Prednisone or Prednisolone
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 66, 84 💬
55Prednisone plus cyclophosphamide
(D00473)		[2] Cyclophosphamide,
Prednisone		[3] Cyclophosphamide ,
Prednisone (D00473),
Cyclophosphamide 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
56Prednisone plus exercise
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
57PredniSONE Tablets USP, 1 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 41, 46 💬
58PredniSONE Tablets USP, 10 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
59PredniSONE Tablets USP, 1mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
60PredniSONE Tablets USP, 2.5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
61PredniSONE Tablets USP, 2.5mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
62PredniSONE Tablets USP, 20mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
63PredniSONE Tablets USP, 5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 41, 46 💬
64PredniSONE Tablets USP, 5mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
65PredniSONE Tablets, USP
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 41, 43, 44 💬
66PredniSONE Tablets, USP 10 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
67PredniSONE Tablets, USP 2.5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
68PredniSONE Tablets, USP 5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
69PredniSONE Tablets, USP, 1 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
70Prednisone therapy and pharmacokinetic
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
71Prednisone treatment
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
72Prednisone with daily edasalonexent
(D00473)		[2] Edasalonexent,
Prednisone		[2] Prednisone (D00473),
Edasalonexent 💬		[2] NR3C1,
RELA 💬		[77] AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬[1] 113 💬
73Prednisone, ciclosporin and mycophenolate mofetil
(D00473)		[4] Cyclosporine,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[4] Cyclosporine ,
Prednisone (D00473),
Mycophenolate mofetil ,
Mycophenolic acid 💬		[8] IMPDH1,
IMPDH2,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[38] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222 💬
74Prednisone, cyclophosphamide
(D00473)		[2] Cyclophosphamide,
Prednisone		[3] Cyclophosphamide ,
Prednisone (D00473),
Cyclophosphamide 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 40 💬
75Prednisone, FK506, MMF
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
76Prednisone, low dose rituximab
(D00473)		[2] Prednisone,
Rituximab		[2] Prednisone (D00473),
Rituximab 💬		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61 💬
77Prednisone, methylprednisolone,cyclophosphamides
(D00473)		[2] Methylprednisolone,
Prednisone		[2] Methylprednisolone ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
78Prednisone/Prednisolone
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 35 💬
79Pyridostigmine, Prednisone, Tacrolimus
(D00473)		[3] Prednisone,
Pyridostigmine,
Tacrolimus		[3] Tacrolimus ,
Prednisone (D00473),
Tacrolimus 💬		[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
80RAYOS (delayed-release prednisone)
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
81Sotatercept with prednisone boost
(D00473)		[2] Prednisone,
Sotatercept		[2] Prednisone (D00473),
Sotatercept 💬		[2] ACVR2A,
NR3C1 💬		[5] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 284 💬
82Tacrolimus combined with prednisone
(D00473)		[2] Prednisone,
Tacrolimus		[3] Tacrolimus ,
Prednisone (D00473),
Tacrolimus 💬		[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222 💬
83Thalidomide, cyclophosphamide and prednisone
(D00473)		[3] Cyclophosphamide,
Prednisone,
Thalidomide		[4] Cyclophosphamide ,
Prednisone (D00473),
Thalidomide ,
Cyclophosphamide 💬		[2] NR3C1,
TNF 💬		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 331 💬
84Treatment systemic therapy (prednisone)
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 162 💬
85Treatment with systemic therapy (prednisone)
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 162 💬
86Vinblastine, vincristine, prednisone, daunorubicin
(D00473)		[4] Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		[4] Prednisone (D00473),
Daunorubicin ,
Vinblastine ,
Vincristine 💬		[12] NR3C1,
TOP2A,
TOP2B,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Platinum drug resistance, Prion disease, Salmonella infection 💬[1] 65 💬